Sorcero Raises $42.5 Million in Series B
Sorcero, a Washington, D.C.-based AI-powered intelligence platform for life sciences, has raised $42.5 million in Series B financing.
The round was led by NewSpring Growth, with participation from Leawood Venture Capital and Blu Ventures.
NewSpring Growth is the dedicated growth equity strategy of NewSpring Capital, a multi-strategy private equity firm with over $3.5 billion under management. They specialize in providing growth-stage capital and strategic guidance to fast-growing companies in the technology, software, and tech-enabled services sectors within the lower-middle market.
The funds will support global expansion across medical affairs, safety, scientific communications, and medical device segments, while scaling Sorcero’s medical-insights–driven engagement platform.
Founded by Dipanwita Das, Richard Graves, and Walter Bender, Sorcero is an AI-powered intelligence platform for the life sciences industry. It helps pharmaceutical, biotech, and medtech companies extract actionable insights from large volumes of scientific and medical data. Sorcero’s solutions support medical affairs, safety monitoring, scientific communications, and market intelligence, leveraging domain-specific Agentic AI. Sorcero’s vision is to create a unified intelligence platform for the precision medicine era. Headquartered in Washington, D.C., the company serves global pharmaceutical companies.
Funding Details
Company: Sorcero, Inc.
Raised: $42.5M
Round: Series B
Funding Date: November 2025
Lead Investor: NewSpring Growth
Additional Investors: Leawood Venture Capital, Blu Ventures
Company Website: https://www.sorcero.com/
Software Category: Life Sciences AI / Data Intelligence